Semaglutide treatment duration varies widely depending on individual factors including baseline weight, metabolic health, lifestyle changes, and personal health goals
Compare mechanisms, endurance effects, and metabolic benefits for Canadians
Originally developed to treat Type 2 diabetes, GLP-1 medications like Ozempic, Wegovy, and Mounjaro have completely reshaped how people think about weight loss
Semaglutide treatment begins with a 0.25 mg injection once per week, then increases by 0.25 mg each week until reaching your therapeutic dose, usually between 1.0 and 2.4 mg weekly
They can facilitate the supply of WEGOVY (prescription medicines) to locations worldwide, including India, while ensuring compliance with legal requirements